Interim / Quarterly Report • Jul 16, 2025
Interim / Quarterly Report
Open in ViewerOpens in native device viewer
A definition or explanation of certain abbreviations, technical terms and other terms used throughout this Statutory Interim Report (also referred to as 'the report' or 'this report') can be found in the chapter Definitions. In some cases, numbers have been rounded for readers' convenience.
This report comprises regulated information within the meaning of articles 1:1 and 5:25d of the Dutch Financial Markets Supervision Act (Wet op het Financieel Toezicht).
In this report the name 'ASML' is sometimes used for convenience in contexts where reference is made to ASML Holding NV and/or any of its subsidiaries and associates, as the context may require.
References to our website in this Statutory Interim Report are for reference only and none nor any portion thereof are incorporated by reference in this report.
© 2025, ASML Holding NV All Rights Reserved.

On July 16, 2025, we published our Statutory Interim Report for the six-month period ended June 29, 2025. This includes the Condensed Consolidated Interim Financial Statements prepared in accordance with IAS 34, "Interim Financial Reporting", as adopted by the European Union.
We also published our 2025 second-quarter results in accordance with US GAAP on July 16, 2025.
This Statutory Interim Report for the six-month period ended June 29, 2025, including the Condensed Consolidated Interim Financial Statements, has not been audited or reviewed by an external auditor.
ASML is a leading supplier to the semiconductor industry. We provide chipmakers with hardware, software and services to mass produce the patterns of integrated circuits (microchips). Together with our partners, we drive the advancement of more affordable, more powerful and more energy-efficient microchips. We enable groundbreaking technology to solve some of humanity's toughest challenges in healthcare, energy use and conservation, mobility and agriculture. Headquartered in Europe's top tech hub, the Brainport Eindhoven region in the Netherlands, we are a global team of more than 44,000 employees (FTEs). Our principal operations are in EMEA, North America and Asia.
The registered office of ASML Holding NV is located at De Run 6501, Veldhoven, the Netherlands. The statutory seat is in Veldhoven. The company is registered with the Dutch Commercial Register under number 17085815.
Our shares are listed for trading in the form of registered shares on Euronext Amsterdam and Nasdaq. The principal trading market of our ordinary shares is Euronext Amsterdam.
Our purpose is to unlock the potential of people and society by pushing technology to new limits. Our vision is that we enable groundbreaking technology to solve some of humanity's toughest challenges.
Our business strategy consists of six priorities that will drive long-term growth
1 Deepen customer trust
In the first half of 2025:
On April 23, 2025, the Annual General Meeting resolved to adopt a final dividend of €1.84 per ordinary share for the year 2024. Recognizing the three interim dividends of €1.52 per ordinary share paid on August 7, 2024, November 7, 2024 and February 19, 2025, the total dividend for the year 2024 was €6.40 per ordinary share. As a result, a total dividend amount of €2.5 billion has been distributed to our shareholders for the year 2024.
An interim dividend for the year 2025 of €1.60 per ordinary share will be made payable on August 6, 2025.
In November 2022, we announced a share buyback program for the period 2022–2025, with a total value of up to €12.0 billion. As part of this program, we expect to allocate up to 2.0 million shares to cover employee share plans. ASML intends to cancel the remaining repurchased shares. As per June 29, 2025, ASML has repurchased approximately 8.8 million shares for an approximate amount of €5.8 billion under this program. The share buyback program may be suspended, modified or discontinued at any time.
Details of the share buyback program as well as transactions pursuant thereto, and details of the dividend are published on ASML's website (www.asml.com/investors).
Set forth below is the Condensed Consolidated Statement of Profit or Loss on a semi-annual basis for the first half of 2024 and 2025 (in accordance with EU-IFRS):
| For the six-month period ended (€, in millions) |
Unaudited June 30, 2024 |
Unaudited % of total net sales |
Unaudited June 29, 2025 |
Unaudited % of total net sales |
Unaudited % change 2025 vs 2024 |
|---|---|---|---|---|---|
| Net system sales | 8,726.8 | 75.7 | 11,336.5 | 73.5 | 29.9 |
| Net service and field option sales | 2,806.0 | 24.3 | 4,096.7 | 26.5 | 46.0 |
| Total net sales | 11,532.8 | 100.0 | 15,433.2 | 100.0 | 33.8 |
| Cost of system sales | (4,241.6) | (36.8) | (5,298.3) | (34.3) | 24.9 |
| Cost of service and field option sales | (1,487.0) | (12.9) | (1,911.5) | (12.4) | 28.5 |
| Total cost of sales | (5,728.6) | (49.7) | (7,209.8) | (46.7) | 25.9 |
| Gross profit | 5,804.2 | 50.3 | 8,223.4 | 53.3 | 41.7 |
| Research and development costs | (1,580.6) | (13.7) | (1,768.2) | (11.5) | 11.9 |
| Selling, general and administrative costs |
(550.2) | (4.8) | (579.4) | (3.8) | 5.3 |
| Operating income | 3,673.4 | 31.9 | 5,875.8 | 38.1 | 60.0 |
| Finance income | 98.2 | 0.9 | 136.2 | 0.9 | 38.7 |
| Finance costs | (83.9) | (0.6) | (62.2) | (0.3) | (25.9) |
| Income before income taxes | 3,687.7 | 32.0 | 5,949.8 | 38.6 | 61.3 |
| Income tax expense | (589.2) | (5.1) | (1,040.4) | (6.7) | 76.6 |
| Income after income taxes | 3,098.5 | 26.9 | 4,909.4 | 31.8 | 58.4 |
| Profit (loss) related to investments in associates |
77.0 | 0.7 | 121.8 | 0.8 | 58.2 |
| Net income | 3,175.5 | 27.5 | 5,031.2 | 32.6 | 58.4 |
The following table shows a summary of key financial figures for the six-month period ended.
| For the six-month period ended (€, in millions, unless otherwise indicated) | Unaudited June 30, 2024 |
Unaudited June 29, 2025 |
Unaudited % change 2025 vs 2024 |
|---|---|---|---|
| Sales | |||
| Total sales of lithography systems (in units) 1 | 170 | 153 | (10.0) |
| Total sales of new lithography systems (in units) 1 | 155 | 140 | (9.7) |
| Total sales of used lithography systems (in units) 1 | 15 | 13 | (13.3) |
| Liquidity | |||
| Cash and cash equivalents | 4,813.6 | 7,243.5 | 50.5 |
| Short-term investments | 205.3 | 5.4 | (97.4) |
| Net cash provided by (used in) operating activities | 1,260.5 | 1,287.4 | 2.1 |
Total net sales for the first half of 2025 increased by 33.8% to €15.4 billion compared to €11.5 billion for the first half of 2024. The increase is primarily due to a favorable NXE product mix and higher sales volumes for EXE, NXE and DUV immersion systems.
The increase in net service and field option sales is driven by net service sales, which continue to scale with a growing installed base, and an increase in net field option sales resulting from achieving NXE performance milestones.
The overall gross profit, as a percentage of total net sales, increased from 50.3% in the first half of 2024 to 53.3% in the first half of 2025, mainly driven by a favorable NXE product mix and an increase in net field option sales.
For the first half of 2025, R&D investments of €2.3 billion (first half of 2024: €2.1 billion) mainly comprised of R&D costs net of credits of €1.8 billion (first half of 2024: €1.6 billion) and net capitalization of development expenditures of €473.9 million (first half of 2024: €447.5 million). The increase in R&D investments across each of our EXE, NXE, DUV and Applications programs all support our holistic lithography solutions.
In the first half of 2025, R&D investments mainly related to:
Selling, general and administrative costs increased to €579.4 million for the first half of 2025 compared to the first half of 2024 (€550.2 million), mainly related to increase in salaries and number of FTEs.
In the first half year of 2025 ASML joined the Brainport Partnerfonds with the goal to, together with the national government, regional authorities and other companies in the region, invest in better accessibility, the accelerated construction of affordable housing, the training of additional technical talent, a balanced labor market, equal opportunities and social cohesion.
The Condensed Consolidated Interim Financial Statements for the six-month period ended June 29, 2025 included in this report have been prepared in accordance with IAS 34, "Interim Financial Reporting", as adopted by the European Union. Our primary accounting standard is US GAAP, the accounting principles generally accepted in the United States of America. The overview below therefore contains a reconciliation of net income in accordance with US GAAP to net income in accordance with EU-IFRS:
| For the six-month period ended (€, in millions) | Unaudited June 30, 2024 |
Unaudited June 29, 2025 |
|---|---|---|
| Net income in accordance with US GAAP | 2,801.7 | 4,645.3 |
| Capitalization of development expenditures and related amortization, net of tax | 367.8 | 389.5 |
| Other | 6.0 | (3.6) |
| Net income in accordance with EU-IFRS | 3,175.5 | 5,031.2 |
Many risks have the potential to impact our business and it is important to understand their nature. We assess risks using the ASML risk universe, which comprises six risk types (Strategy and products, Finance and reporting, Partners, People, Operations, Legal and compliance).
The risk factors in this section are classified under the six risk types as presented in our 2024 Annual Report. No new risk factors were added in this report.
Any of these risks and the related events or circumstances described therein may have a material adverse effect on our business, financial condition, results of operations and reputation.
These risks are not the only ones that we face. Some risks may not yet be known to us, and certain risks that we do not currently believe to be material could become material in the future.
Many risks are intensified by global events, such as wars and other conflicts, geopolitical tensions, inflation, industry downturn, global measures (including new regulations and tariffs) taken in response to these events and/or any adverse global business and economic conditions.
Risk category: Product roadmap execution, Innovation
• We face intense competition
Risk category: Competition
• Failure to adequately protect intellectual property could harm our business
Risk category: Intellectual property rights
• We may be unable to make desirable acquisitions or to integrate successfully any businesses we acquire
• We may not be able to achieve our ESG objectives or adapt and respond in a timely manner to emerging ESG expectations and regulations
| Risk category: | ESG expectations, Product stewardship |
|---|---|
• We are exposed to financial risks including liquidity risk, interest rate risk, counterparty credit risk, foreign exchange risk and inflation risk
• Our success is highly dependent on the performance of a limited number of critical suppliers of single-source key components
Risk category: Supply chain disruption, Supplier strategy and performance
• A high percentage of net sales is derived from a few customers
Risk category: Customer dependency
Risk category: Human resources, Knowledge management, Organizational effectiveness
• We may face challenges in managing the industrialization of our products and bringing them to high-volume production
• We are dependent on the continued operation of a limited number of manufacturing facilities
Risk category: Continuity of own operations
• We face challenges to meet expected demand
Risk category: Manufacturing and install, Human resources, Supplier strategy and performance
• Our operations expose us to health, safety and environment risks
• Cybersecurity and other security incidents, or disruptions in our processes or information technology systems, could materially adversely affect our business operations
Risk category: Security, Information technology, Process effectiveness and efficiency
• We are subject to regulatory and compliance obligations in the various countries where we operate and the complexity of compliance requirements increases
Risk category: Violation of laws and regulations
While there are increased uncertainties, ASML sees strong demand for its AI customers on both Logic and Memory.
In relation to our EUV technology, customers continue to add capacity on the leading edge to support AI demand, in which EUV plays an important role. For example DRAM customers have recently mentioned an increase in the number of EUV layers on their latest and future nodes. In 2025, ASML expects its advanced customers to add about 30% more EUV capacity compared to full year 2024. The higher productivity from NXE:3800E means that ASML can address that capacity increase with about the same number of systems as in 2024 but of course with higher average selling price and improved gross margin.
When it comes to net service and field option sales, the upgrade business has been strong in the first half of 2025 as ASML executed the productivity upgrades of the NXE:3800E. In addition, ASML expects continued strength in its service business through the second half of 2025 as its installed base grows, and NXE systems come out of warranty.
ASML expects a full-year 2025 revenue increase of around 15% relative to 2024.
Looking at 2026, ASML sees that our AI customers' fundamentals remain strong. At the same time, ASML continues to see increasing uncertainty driven by macro-economic and geopolitical developments. Therefore, while ASML still prepares for growth in 2026, ASML cannot confirm it at this stage.
The Board of Management hereby declares that, to the best of its knowledge, the Condensed Consolidated Interim Financial Statements are prepared in accordance with IAS 34, "Interim Financial Reporting", as adopted by the European Union, and provide a true and fair view of the assets, liabilities, financial position and profit or loss of ASML Holding NV and the undertakings included in the consolidation taken as a whole and that the Interim Management Report includes a fair review of the information required pursuant to section 5:25d(8)/(9) of the Dutch Financial Markets Supervision Act (Wet op het Financieel Toezicht).
The Board of Management,
Christophe D. Fouquet Roger J.M. Dassen Wayne R. Allan James (Jim) P. Koonmen Frédéric J.M. Schneider-Maunoury
Veldhoven, July 16, 2025

| Unaudited For the six-month period ended (€, in millions, except per share data) Notes June 30, 2024 |
Unaudited June 29, 2025 |
|---|---|
| Net system sales 2, 3 8,726.8 |
11,336.5 |
| Net service and field option sales 2,806.0 |
4,096.7 |
| Total net sales 3 11,532.8 |
15,433.2 |
| Cost of system sales (4,241.6) |
(5,298.3) |
| Cost of service and field option sales (1,487.0) |
(1,911.5) |
| Total cost of sales (5,728.6) |
(7,209.8) |
| Gross profit 5,804.2 |
8,223.4 |
| Research and development costs (1,580.6) |
(1,768.2) |
| Selling, general and administrative costs | (550.2) (579.4) |
| Operating income 3,673.4 |
5,875.8 |
| Finance income | 98.2 136.2 |
| Finance costs | (83.9) (62.2) |
| Income before income taxes 3,687.7 |
5,949.8 |
| Income tax expense 6 |
(589.2) (1,040.4) |
| Income after income taxes 3,098.5 |
4,909.4 |
| Profit (loss) related to investments in associates | 77.0 121.8 |
| Net income 3,175.5 |
5,031.2 |
| Basic net income per ordinary share 8 |
8.07 12.89 |
| Diluted net income per ordinary share 8 |
8.07 12.89 |
| Weighted average number of shares outstanding 8 |
393.3 390.2 |
| Diluted weighted average number of shares 8 |
393.6 390.4 |
| Unaudited For the six-month period ended (€, in millions) June 30, 2024 |
Unaudited June 29, 2025 |
|---|---|
| Net income 3,175.5 |
5,031.2 |
| Other comprehensive income: | |
| Proportionate share of other comprehensive income from associates (1.8) |
0.6 |
| Foreign currency translation, net of taxes: | |
| Gain (loss) on foreign currency translation 77.1 |
(181.7) |
| Financial instruments, net of taxes: | |
| Gain (loss) on derivative financial instruments 21.5 |
(71.6) |
| Transfers to net income (7.1) |
(4.1) |
| Other comprehensive income, net of taxes 1 89.7 |
(256.8) |
| Total comprehensive income, net of taxes 3,265.2 |
4,774.4 |
| Attributable to equity holders 3,265.2 |
4,774.4 |
(Before appropriation of net income)
| (€, in millions) | Notes | December 31, 2024 |
Unaudited June 29, 2025 |
(€, in millions) | December 31, Notes 2024 |
Unaudited June 29, 2025 |
|---|---|---|---|---|---|---|
| Assets | Equity and liabilities | |||||
| Finance receivables, net | 317.2 | 175.1 | ||||
| Deferred tax assets | 6 | 2,168.6 | 2,025.8 | Shareholders' equity | 22,021.9 | 21,531.7 |
| Loans receivable | 1,456.7 | 1,444.9 | ||||
| Other assets | 790.8 | 837.3 | Long-term debt | 3,677.3 | 3,698.9 | |
| Derivative financial instruments | 9 | — | 6.4 | Deferred and other income tax liabilities | 6 732.9 |
796.3 |
| Investments in associates | 903.0 | 1,029.2 | Contract liabilities | 5,625.4 | 4,187.1 | |
| Goodwill | 4,610.1 | 4,610.1 | Accrued and other liabilities | 430.2 | 406.3 | |
| Intangible assets, net | 4,728.9 | 5,143.5 | Derivative financial instruments | 9 29.3 |
27.8 | |
| Property, plant and equipment, net | 6,846.8 | 7,296.0 | Total non-current liabilities | 10,495.1 | 9,116.4 | |
| Right-of-use assets | 387.2 | 365.0 | ||||
| Total non-current assets | 22,209.3 | 22,933.3 | Accounts payable | 3,498.5 | 3,090.2 | |
| Accrued and other liabilities | 2,602.3 | 2,841.3 | ||||
| Cash and cash equivalents | 4 | 12,735.9 | 7,243.5 | Derivative financial instruments | 9 84.3 |
151.5 |
| Short-term investments | 4 | 5.4 | 5.4 | Current tax liabilities | 6 283.3 |
442.6 |
| Accounts receivable, net | 4,477.5 | 4,996.9 | Current portion of long-term debt | 1,010.3 | 1,006.9 | |
| Finance receivables, net | 82.6 | 531.1 | Contract liabilities | 12,570.8 | 11,083.1 | |
| Contract assets | 320.6 | 275.3 | Total current liabilities | 20,049.5 | 18,615.6 | |
| Current tax assets | 6 | 283.6 | 98.5 | |||
| Inventories, net | 10,891.5 | 11,575.8 | ||||
| Loans receivable | 0.0 | 17.8 | ||||
| Other assets | 1,463.6 | 1,499.5 | ||||
| Derivative financial instruments | 9 | 96.5 | 86.6 | |||
| Total current assets | 30,357.2 | 26,330.4 | ||||
| Total assets | 52,566.5 | 49,263.7 | Total equity and liabilities | 52,566.5 | 49,263.7 |
(Before appropriation of net income 2025)
| Issued and Outstanding Shares | ||||||||
|---|---|---|---|---|---|---|---|---|
| (€, in millions) | Number | Share Capital | Share Premium |
Treasury Shares at Cost |
Retained Earnings |
Other 1 Reserves |
Net Income | Total |
| Balance at January 1, 2024 | 393.5 | 36.0 | 4,493.9 | (3,306.2) | 3,502.8 | 3,367.8 | 8,115.2 | 16,209.5 |
| Prior year net income | — | — | — | — | 8,115.2 | — | (8,115.2) | — |
| Components of comprehensive income: | ||||||||
| Net income | — | — | — | — | — | — | 3,175.5 | 3,175.5 |
| Proportionate share of other comprehensive income from associates | — | — | — | — | — | (1.8) | — | (1.8) |
| Gain (loss) on foreign currency translation | — | — | — | — | — | 77.1 | — | 77.1 |
| Gain (loss) on financial instruments | — | — | — | — | — | 14.4 | — | 14.4 |
| Total comprehensive income | — | — | — | — | — | 89.7 | 3,175.5 | 3,265.2 |
| Purchases of treasury shares | (0.6) | — | — | (500.0) | — | — | — | (500.0) |
| Cancellation of treasury shares | — | — | — | — | — | — | — | — |
| Share-based payments | — | — | 77.7 | — | — | — | — | 77.7 |
| Issuance of shares | 0.3 | — | (116.7) | 198.4 | (21.2) | — | — | 60.5 |
| Dividend paid | — | — | — | — | (1,259.3) | — | — | (1,259.3) |
| Development expenditures | — | — | — | — | (447.4) | 447.4 | — | — |
| Balance at June 30, 2024 (unaudited) | 393.2 | 36.0 | 4,454.9 | (3,607.8) | 9,890.1 | 3,904.9 | 3,175.5 | 17,853.6 |
| Components of comprehensive income: | ||||||||
| Net income | — | — | — | — | — | — | 5,173.5 | 5,173.5 |
| Proportionate share of other comprehensive income from associates | — | — | — | — | — | (10.3) | — | (10.3) |
| Gain (loss) on foreign currency translation | — | — | — | — | — | 15.9 | — | 15.9 |
| Gain (loss) on financial instruments | — | — | — | — | — | 14.9 | — | 14.9 |
| Total comprehensive income | — | — | — | — | — | 20.5 | 5,173.5 | 5,194.0 |
(Before appropriation of net income 2025)
| Issued and Outstanding Shares | ||||||||
|---|---|---|---|---|---|---|---|---|
| (€, in millions) | Number | Share Capital | Share Premium |
Treasury Shares at Cost |
Retained Earnings |
Other 1 Reserves |
Net Income | Total |
| Purchases of treasury shares | — | (0.1) | — | 0.1 | — | — | — | 0.0 |
| Cancellation of treasury shares | — | (0.5) | — | 3,050.4 | (3,049.9) | — | — | — |
| Share-based payments | — | — | 104.4 | — | — | — | — | 104.4 |
| Issuance of shares | 0.1 | — | (5.0) | 81.3 | (12.8) | — | — | 63.5 |
| Dividend paid | — | — | — | — | (1,193.6) | — | — | (1,193.6) |
| Development expenditures | — | — | — | — | (467.2) | 467.2 | — | — |
| Balance at December 31, 2024 | 393.3 | 35.4 | 4,554.3 | (476.0) | 5,166.6 | 4,392.6 | 8,349.0 | 22,021.9 |
| Prior year net income | — | — | — | — | 8,349.0 | — | (8,349.0) | — |
| Components of comprehensive income: | ||||||||
| Net income | — | — | — | — | — | — | 5,031.2 | 5,031.2 |
| Proportionate share of other comprehensive income from associates | — | — | — | — | — | 0.6 | — | 0.6 |
| Gain (loss) on foreign currency translation | — | — | — | — | — | (181.7) | — | (181.7) |
| Gain (loss) on financial instruments | — | — | — | — | — | (75.7) | — | (75.7) |
| Total comprehensive income | — | — | — | — | — | (256.8) | 5,031.2 | 4,774.4 |
| Purchases of treasury shares | (6.2) | — | — | (4,102.5) | — | — | — | (4,102.5) |
| Cancellation of treasury shares | — | — | — | — | — | — | — | — |
| Share-based payments | — | — | 75.1 | — | — | — | — | 75.1 |
| Issuance of shares | 0.3 | — | (139.6) | 298.4 | (84.4) | — | — | 74.4 |
| Dividend paid | — | — | — | — | (1,311.6) | — | — | (1,311.6) |
| Development expenditures | — | — | — | — | (473.8) | 473.8 | — | — |
| Balance at June 29, 2025 (unaudited) | 387.4 | 35.4 | 4,489.8 | (4,280.1) | 11,645.8 | 4,609.6 | 5,031.2 | 21,531.7 |
| For the six-month period ended (€, in millions) | Notes | Unaudited June 30, 2024 |
Unaudited June 29, 2025 |
|---|---|---|---|
| Cash flows from operating activities | |||
| Net income | 3,175.5 | 5,031.2 | |
| Adjustments to reconcile net income to net cash flows from operating activities: | |||
| Depreciation and amortization1 | 580.8 | 616.7 | |
| Impairment and loss on disposal | 17.9 | 18.6 | |
| Share-based compensation expense | 77.7 | 75.1 | |
| Inventory reserves | 232.2 | 159.3 | |
| Deferred tax expense (benefit) | 84.8 | 201.2 | |
| Investments in associates | (84.5) | (125.6) | |
| Changes in assets and liabilities: | |||
| Accounts receivable, net | (151.1) | (527.9) | |
| Finance receivables, net | 393.6 | (306.4) | |
| Inventories | (2,059.6) | (648.8) | |
| Other assets | (744.8) | (533.1) | |
| Accrued and other liabilities | (166.0) | 149.4 | |
| Accounts payable | 890.3 | (317.8) | |
| Current tax assets and liabilities | 6 | 25.7 | 361.9 |
| Contract assets and liabilities | (1,012.0) | (2,866.4) | |
| Net cash provided by (used in) operating activities | 1,260.5 | 1,287.4 | |
| Cash flows from investing activities | |||
| Purchase of property, plant and equipment | (948.3) | (829.8) | |
| Purchase of intangible assets | (565.4) | (575.0) | |
| Purchase of short-term investments | 4 | (300.5) | — |
| Maturity of short-term investments | 4 | 100.5 | — |
| Loans issued and repayment thereof | 0.5 | 1.7 | |
| Net cash used in investing activities | (1,713.2) | (1,403.1) |
| For the six-month period ended (€, in millions) | Notes | Unaudited June 30, 2024 |
Unaudited June 29, 2025 |
|---|---|---|---|
| Cash flows from financing activities | |||
| Dividend paid | 7 | (1,259.3) | (1,311.6) |
| Purchase of treasury shares | 7 | (500.0) | (4,077.8) |
| Net proceeds from issuance of shares | 60.5 | 74.4 | |
| Repayment of debt and lease obligations | (38.1) | (39.1) | |
| Net cash used in financing activities | (1,736.9) | (5,354.1) | |
| Net cash flows | (2,189.6) | (5,469.8) | |
| Effect of changes in exchange rates on cash | (1.5) | (22.6) | |
| Net increase (decrease) in cash and cash equivalents | (2,191.1) | (5,492.4) | |
| Cash and cash equivalents at beginning of the year | 7,004.7 | 12,735.9 | |
| Cash and cash equivalents at June 30, 2024 and June 29, 2025 | 4,813.6 | 7,243.5 | |
| Supplemental Disclosures of Cash Flow Information | |||
| Unpaid portion of property, plant and equipment, excluded in investing activities, included in accounts payable |
(17.4) | (89.6) | |
| Interest received | 93.3 | 129.4 | |
| Interest paid | (84.4) | (65.6) | |
| Income taxes paid, net of refunds | 6 | (452.9) | (613.7) |
ASML is a leading supplier to the semiconductor industry. The company provides chipmakers with hardware, software and services to mass produce the patterns of integrated circuits (microchips). Together with its partners, ASML drives the advancement of more affordable, more powerful, more energy-efficient microchips. ASML enables groundbreaking technology to solve some of humanity's toughest challenges, such as in healthcare, energy use and conservation, mobility and agriculture. ASML is a multinational company headquartered in Veldhoven, the Netherlands, with offices across EMEA, the US and Asia. Every day, ASML's more than 44,000 employees (FTE) challenge the status quo and push technology to new limits.
The registered office and statutory seat of ASML Holding NV is located at De Run 6501, Veldhoven, the Netherlands. The company is registered with the Dutch Commercial Register under number 17085815.
Our shares are listed for trading in the form of registered shares on Euronext Amsterdam and Nasdaq under the symbol ASML. The principal trading market of our ordinary shares is Euronext Amsterdam.
The Condensed Consolidated Interim Financial Statements were authorized for issuance by the Board of Management on July 16, 2025 and have not been audited or reviewed by an external auditor.
The Condensed Consolidated Interim Financial Statements for the six-month period ended June 29, 2025 have been prepared in accordance with IAS 34, "Interim Financial Reporting", as adopted by the European Union, and therefore do not include all the information and disclosures as required in an Annual Report based on EU-IFRS. These financial statements should be read in conjunction with the 2024 Annual Report based on EU-IFRS and the additional requirements of Article 362.9 of Book 2 of the Dutch Civil Code.
The Condensed Consolidated Interim Financial Statements are stated in millions of euros unless indicated otherwise.
The accounting policies adopted in the preparation of the Condensed Consolidated Interim Financial Statements are consistent with those applied in the preparation of the 2024 Annual Report based on EU-IFRS.
In the process of applying our accounting policies, management has made some judgments that have significant effect on the amounts recognized in the Condensed Consolidated Interim Financial Statements. The critical accounting judgments and key sources of estimation are subject to volatility and uncertainty. Estimates and assumptions used in the preparation of the Condensed Consolidated Interim Financial Statements are considered consistent with those described in the 2024 Annual Report based on EU-IFRS.
Net system sales per technology were as follows:
| For the six-month period ended | June 30, 2024 | June 29, 2025 | |||
|---|---|---|---|---|---|
| Unaudited Net system sales (in units) |
Unaudited Net system sales (€, in millions) |
Unaudited Net system sales (in units) |
Unaudited Net system sales (€, in millions) |
||
| EXE | — | — | 1 | 273.8 | |
| NXE | 19 | 3,290.6 | 24 | 5,593.2 | |
| ArF immersion | 52 | 3,916.8 | 56 | 4,301.7 | |
| ArF dry | 15 | 425.6 | 7 | 193.3 | |
| KrF | 58 | 743.7 | 38 | 495.6 | |
| I-line | 26 | 151.3 | 27 | 158.0 | |
| Metrology & Inspection | 58 | 198.8 | 88 | 320.9 | |
| Total | 228 | 8,726.8 | 241 | 11,336.5 |
Net system sales per end-use were as follows:
| For the six-month period ended | June 30, 2024 | June 29, 2025 | ||
|---|---|---|---|---|
| Unaudited Net system sales (in units) |
Unaudited Net system sales (€, in millions) |
Unaudited Net system sales (in units) |
Unaudited Net system sales (€, in millions) |
|
| Logic | 164 | 5,076.5 | 157 | 7,157.6 |
| Memory | 64 | 3,650.3 | 84 | 4,178.9 |
| Total | 228 | 8,726.8 | 241 | 11,336.5 |
During the first half of 2025, €1,469.5 million of receivables were sold through factoring arrangements (first half of 2024: €370.2 million). Factored receivables are treated as net cash provided by operating activities within the Condensed Consolidated Statement of Cash Flows.
ASML has one reportable segment, since we are a holistic lithography solution provider, for the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems, consisting of lithography, metrology and inspection systems. The Chief Operating Decision Maker regularly sets and monitors goals and boundaries on a consolidated basis to make decisions about resource allocation and assess performance. ASML's Chief Operating Decision Maker is the combination of the functions of the CEO and CFO.
Net system sales for new and used systems were as follows:
| For the six-month period ended (€, in millions) | Unaudited June 30, 2024 |
Unaudited June 29, 2025 |
|---|---|---|
| New systems | 8,468.5 | 11,046.6 |
| Used systems | 258.3 | 289.9 |
| Net system sales | 8,726.8 | 11,336.5 |
For geographical reporting, total net sales are attributed to the geographic location in which the customers' facilities are located.
Total net sales by geographic region were as follows:
| For the six-month period ended (€, in millions) | Unaudited June 30, 2024 |
Unaudited June 29, 2025 |
|---|---|---|
| Japan | 218.1 | 492.9 |
| South Korea | 2,955.0 | 4,413.6 |
| Singapore | 161.2 | 194.3 |
| Taiwan | 1,503.4 | 4,361.9 |
| China | 4,798.9 | 3,712.3 |
| Rest of Asia | 1.4 | 1.2 |
| EMEA | 1,166.5 | 314.2 |
| United States | 728.3 | 1,942.8 |
| Total | 11,532.8 | 15,433.2 |
Our principal sources of liquidity consist of:
| December 31, | Unaudited | |
|---|---|---|
| (€, in millions) | 2024 | June 29, 2025 |
| Cash and cash equivalents | 12,735.9 | 7,243.5 |
| Short-term investments | 5.4 | 5.4 |
| Available committed credit facilities1 | 1,500.0 | 1,500.0 |
ASML also has non-committed lines of credit available. These facilities provide ASML with the ability to request shortterm unsecured loans from time to time for an aggregate amount of €2.75 billion (€2.75 billion as of December 31, 2024). No amounts have been drawn under these lines of credit. Outstanding amounts under the non-committed facility will bear interest based on market conditions at the moment of draw down.
In 2024 ASML entered into a €1.5 billion Euro Commercial Paper (ECP) program. The program allows ASML to issue commercial paper up to 364 days in tenor, in a number of currencies. As of June 29, 2025, there is no commercial paper outstanding under this program.
Our liquidity needs are affected by many factors, including the risk factors as specified in the Risk factors section in the 2024 Annual Report based on EU-IFRS and in this 2025 Statutory Interim Report.
Although our cash requirements fluctuate based on the timing and the extent to which these risks materialize, we believe that cash generated from operating activities, together with our other sources of liquidity are sufficient to satisfy our expected requirements, including our expected capital expenditures, research and development investments and debt servicing.
The nature, scale and scope of the commitments, contingencies and guarantees are in line with those disclosed in the 2024 Annual Report based on EU-IFRS.
Income tax expense is recognized based on management's estimate of the expected annualized income tax rate for the full financial year, as well as discrete items recognized in the first half of the year. Our effective tax rate for the sixmonth period ended June 29, 2025 is 17.5 percent compared to 16.0 percent for the six-month period ended June 30, 2024. The increase in effective tax rate is mainly driven by movements in our liability for uncertain tax positions.
ASML falls within the scope of the OECD Global minimum tax rules. Global minimum tax legislation was enacted in the Netherlands, the jurisdiction in which ASML is incorporated, and came into effect from January 1, 2024. ASML applies the temporary mandatory relief from deferred tax accounting for the impacts of Global minimum tax, as provided in the amendments to IAS 12 issued in May 2023.
ASML recognized an estimated current tax expense related to Global minimum tax amounting to €0.2 million..
On April 23, 2025, the Annual General Meeting resolved to adopt a final dividend of €1.84 per ordinary share for the year 2024. Recognizing the three interim dividends of €1.52 per ordinary share paid on August 7, 2024, November 7, 2024 and February 19, 2025, the total dividend for the year 2024 was €6.40 per ordinary share. As a result, a total dividend amount of €2.5 billion has been distributed to our shareholders for the year 2024.
In November 2022, we announced a share buyback program for the period 2022–2025, with a total value of up to €12.0 billion. As part of this program, we expect to allocate up to 2.0 million shares to cover employee share plans. ASML intends to cancel the remaining repurchased shares. As per June 29, 2025, ASML has repurchased approximately 8.8 million shares for an approximate amount of €5.8 billion under this program. The share buyback program may be suspended, modified or discontinued at any time.
Basic net income per ordinary share is calculated by dividing net income by the weighted average number of ordinary shares outstanding for that period.
The dilutive effect is calculated using the treasury stock method by dividing net income by the weighted average number of ordinary shares outstanding for that period plus shares applicable to options and conditional shares (dilutive potential ordinary shares). The calculation of diluted net income per ordinary share does not assume exercise of options when exercise would be anti-dilutive. Excluded from the diluted weighted average number of shares outstanding calculation are cumulative preference shares contingently issuable to the preference share foundation, since they represent a different class of stock from the ordinary shares.
The basic and diluted net income per ordinary share has been calculated as follows:
| For the six-month period ended (€, in millions, except per share data) | Unaudited June 30, 2024 |
Unaudited June 29, 2025 |
|---|---|---|
| Net income | 3,175.5 | 5,031.2 |
| Weighted average number of shares outstanding | 393.3 | 390.2 |
| Basic net income per ordinary share | 8.07 | 12.89 |
| Weighted average number of shares outstanding | 393.3 | 390.2 |
| Plus shares applicable to options and conditional shares | 0.3 | 0.2 |
| Diluted weighted average number of shares | 393.6 | 390.4 |
| Diluted net income per ordinary share | 8.07 | 12.89 |
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement hierarchy prioritizes the inputs to valuation techniques used to measure fair value as follows:
The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities (level 1) and the lowest priority to unobservable inputs (level 3). A financial instrument's fair value classification is based on the lowest level of any input that is significant in the fair value measurement hierarchy. For assets and liabilities that are recognized at fair value on a recurring basis, we determine whether transfers have occurred between levels in the hierarchy by re-assessing categorization (based on the lowest level input that is significant to the fair value measurement as a whole) at the end of each reporting period.
Investments in money market funds (included in our cash and cash equivalents) have fair value measurements which are all based on quoted prices for identical assets or liabilities.
Our short-term investments consist of deposits with original maturities to the entity holding the investments longer than three months and one year or less at the date of acquisition with financial institutions that have investment-grade credit ratings. The fair value of the deposits is determined with reference to quoted market prices in an active market for similar assets or discounted cash flow analysis.
The principal market in which we execute our derivative contracts is the institutional market in an over-the-counter environment with a high level of price transparency. The market participants usually are large commercial banks. The valuation inputs for our derivative contracts are based on quoted prices and quoting pricing intervals from public data sources; they do not involve management judgment.
The valuation technique used to determine the fair value of forward foreign exchange contracts (used for hedging purposes) approximates the net present value technique which is the estimated amount that a bank would receive or pay to terminate the forward foreign exchange contracts at the reporting date, taking into account current interest rates and current exchange rates.
The valuation technique used to determine the fair value of interest rate swaps (used for hedging purposes) is the net present value technique, which is the estimated amount that a bank would receive or pay to terminate the swap agreements at the reporting date, taking into account current interest rates.
Four out of six of our outstanding Eurobonds, with a combined principal amount of €3.25 billion, serve as hedged items in fair value hedge relationships in which we hedge the variability of changes in the fair value of our Eurobonds due to changes in market interest rates with interest rate swaps. For two out of six of our outstanding Eurobonds, with a combined principal amount of €1.5 billion, no hedging is applied. The fair value changes of the interest rate swaps are recorded on the Condensed Consolidated Statement of Financial Position under derivative financial instruments and the carrying amounts of the Eurobonds are adjusted for the effective portion of these fair value changes only.
The following tables present our financial assets and financial liabilities that are measured at fair value on a recurring basis and the assets and liabilities for which the fair value is only disclosed:
| Unaudited As of June 29, 2025 (€, in millions) | Level 1 | Level 2 | Level 3 | Total |
|---|---|---|---|---|
| Assets measured at fair value | ||||
| Derivative financial instruments 1 | — | 93.0 | — | 93.0 |
| Money market funds 2 | 3,210.4 | — | — | 3,210.4 |
| Short-term investments 3 | — | 5.4 | — | 5.4 |
| Total | 3,210.4 | 98.4 | — | 3,308.8 |
| Liabilities measured at fair value | ||||
| Derivative financial instruments 1 | — | 179.3 | — | 179.3 |
| Assets and Liabilities for which fair values are disclosed |
||||
| Loans receivable 4 | — | — | 1,379.2 | 1,379.2 |
| Long-term debt 5 | 4,589.0 | — | — | 4,589.0 |
| As of December 31, 2024 (€, in millions) | Level 1 | Level 2 | Level 3 | Total |
| Assets measured at fair value | ||||
| Derivative financial instruments 1 | — | 96.5 | — | 96.5 |
| Money market funds 2 | 6,379.2 | — | — | 6,379.2 |
| Short-term investments 3 | — | 5.4 | — | 5.4 |
| Total | 6,379.2 | 101.9 | — | 6,481.1 |
| Liabilities measured at fair value | ||||
| Derivative financial instruments 1 | — | 113.6 | — | 113.6 |
| Assets and Liabilities for which fair values are disclosed |
||||
| Loans receivable 4 | — | — | 1,339.4 | 1,339.4 |
| Long-term debt 5 | 4,561.8 | — | — | 4,561.8 |
Derivative financial instruments consist of forward foreign exchange contracts and interest rate swaps.
Money market funds are part of our cash and cash equivalents.
Short-term investments consist of deposits with original maturities to the entity holding the investments longer than three months, but one year or less at the date of acquisition. These deposits are valued at amortized costs which is close to their fair value. Their fair value is determined
with reference to quoted market prices in an active market for similar assets or discounted cash flow analysis.
Loans receivable mainly relates to Carl Zeiss SMT GmbH.
Long-term debt mainly relates to Eurobonds.
There were no transfers between the levels of the fair value hierarchy during the first half of 2025 and the full year 2024.
The carrying amount of cash and cash equivalents, accounts payable, and other current financial assets and liabilities approximate their fair value because of the short-term nature of these instruments. The fair value of the loan to Carl Zeiss SMT GmbH is determined using a discounted cash flow model, which considers the present value of expected cash receipts, discounted using a risk-adjusted discount rate.
Money market and investment funds qualify as available for sale securities. Due to the short-term nature and investment-grade credit ratings, the fair value is close to the carrying value. These money market funds can be called on a daily basis. Investments and redemptions in money market funds are managed on a daily basis based triggered through actual cash balances. ASML does not have trading securities as of June 29, 2025.
The deposits as part of the cash and cash equivalents and short-term investments qualify as securities held to maturity. The amortized cost value is close to the fair value and carrying value due to short-term nature and since related to investment with investment-grade credit ratings. Maturities are one year or less. No held to maturity securities were sold before expiration date.
For the six-month period ended June 29, 2025 and the year ended December 31, 2024, we had no significant fair value measurements on a non-recurring basis from regular business activities.
An interim dividend for the year 2025 of €1.60 per ordinary share will be made payable on August 6, 2025.
Veldhoven, the Netherlands July 16, 2025
Prepared by The Board of Management: Christophe D. Fouquet Roger J.M. Dassen Wayne R. Allan James (Jim) P. Koonmen Frédéric J.M. Schneider-Maunoury
This document and related discussions contain statements that are forward-looking within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, including statements with respect to plans, strategies, expected trends, including trends in the semiconductor industry and end markets and business environment trends, expected growth in the semiconductor industry by 2030, our expectation that AI will be the key driver for the industry and the expected impact of AI demand on our business and results, our expectation that lithography will remain at the heart of customer innovation, expected demand, bookings, outlook of market segments, outlook and expected financial results including 2025 second-half outlook, expected results for Q3 2025, including net sales, Installed Base Management sales, gross margin, R&D costs, SG&A costs, outlook for full year 2025, including expected full year 2025 total net sales, gross margin, estimated annualized effective tax rate and expected IBM sales, expected full-year net sales growth percentage relative to 2024, current expectations relating to 2026 including expected drivers and uncertainties and preparation for growth in 2026, statements made at our 2024 Investor Day, including modelled revenue and gross margin opportunity for 2030, statements with respect to tariff announcements and the expected impact of such tariffs on our business and results, our expectation to continue to return significant amounts of cash to shareholders through growing dividends and share buybacks, statements with respect to our share buyback program, and statements with respect to dividends, statements with respect to expected performance and capabilities of our systems and customer plans, statements with respect to our ESG
strategy and commitments and other non-historical statements. You can generally identify these statements by the use of words like "may", "expect", "will", "could", "should", "project", "believe", "anticipate", "expect", "plan", "estimate", "forecast", "potential", "intend", "continue", "target", "future", "progress", "goal", "model", "opportunity", "commitment" and variations of these words or comparable words. These statements are not historical facts, but rather are based on current expectations, estimates, assumptions, plans and projections about our business and our future financial results and readers should not place undue reliance on them. Forward-looking statements do not guarantee future performance and involve a number of substantial known and unknown risks and uncertainties. These risks and uncertainties include, without limitation, risks relating to customer demand, semiconductor equipment industry capacity, worldwide demand for semiconductors and semiconductor manufacturing capacity, lithography tool utilization and semiconductor inventory levels, general trends and consumer confidence in the semiconductor industry, the impact of general economic conditions, including the impact of the current macroeconomic environment on the semiconductor industry, semiconductor market conditions, the ultimate impact of AI on our industry and business, the impact of inflation, interest rates, wars and geopolitical developments, the impact of pandemics, the performance of our systems, the success of technology advances and the pace of new product development and customer acceptance of and demand for new products, our production capacity and ability to adjust capacity to meet demand, supply chain capacity, timely availability of parts and components, raw materials, critical manufacturing
equipment and qualified employees, our ability to produce systems to meet demand, the number and timing of systems ordered, shipped and recognized in revenue, risks relating to fluctuations in net bookings and our ability to convert bookings into sales, the risk of order cancellation, delays or push outs and restrictions on shipments of ordered systems under export controls, risks relating to the trade environment, import/export and national security regulations and orders and their impact on us, including the impact of changes in export regulations and the impact of such regulations on our ability to obtain necessary licenses and to sell our systems and provide services to certain customers, the impact of the tariff announcements, exchange rate fluctuations, changes in tax rates, available liquidity and free cash flow and liquidity requirements, our ability to refinance our indebtedness, available cash and distributable reserves for, and other factors impacting, dividend payments and share repurchases, the number of shares that we repurchase under our share repurchase program, our ability to enforce patents and protect intellectual property rights and the outcome of intellectual property disputes and litigation, our ability to meet ESG goals and commitments and execute our ESG strategy, other factors that may impact ASML's business or financial results, and other risks indicated in the risk factors included in ASML's Annual Report on Form 20-F for the year ended December 31, 2024 and other filings with and submissions to the US Securities and Exchange Commission. These forward-looking statements are made only as of the date of this document. We undertake no obligation to update any forward-looking statements after the date of this report or to conform
such statements to actual results or revised expectations, except as required by law.
October 15, 2025 Announcement of third quarter results for 2025
December 31, 2025 End of ASML's 2025 fiscal year
Announcement of fourth quarter and annual results for 2025
April 22, 2026 Annual General Meeting of Shareholders
ASML Investor Relations supplies information regarding the company and its business opportunities to investors and financial analysts. Annual reports, quarterly releases and other information are also available on our website (www.asml.com).
De Run 6501 5504 DR Veldhoven The Netherlands
P.O. Box 324 5500 AH Veldhoven The Netherlands
Phone: +31 40 268 3938 Email: [email protected] For additional contact information please visit asml.com
| Name | Description | Name | Description |
|---|---|---|---|
| A | I | ||
| AI | Artificial intelligence | IAS | International accounting standards |
| ArF | Argon fluoride | i-line | Light with a wavelength of 365 nm, generated by mercury vapor lamps and used in some lithography systems. |
| ASML | ASML Holding NV and/or any of its subsidiaries and associates | ||
| B | Immersion | A lithography technique that uses a pool of ultrapure water between the lens and the wafer to increase the lens's numerical aperture (ability to collect and focus light). This improves both the |
|
| Brainport Eindhoven | A technology region in the south of the Netherlands comprising companies, educational institutions and governmental organizations. |
resolution and depth of focus for the lithography system. | |
| C | KrF | Krypton fluoride | |
| Code | The Dutch Corporate Governance Code | L | |
| Code of Conduct | Code of ethics and conduct | Lithography | Lithography, or photolithography, is the process in microchip manufacturing that uses light to pattern parts on a silicon wafer. |
| D DRAM |
Dynamic random-access memory | Logic | Integrated devices such as microprocessors, microcontrollers and graphics processing units. Also refers to companies that manufacture such devices. |
| DUV | A lithography technology that uses deep ultraviolet (DUV) light | M | |
| E | Memory Microchips, such as NAND Flash and DRAM, that store information. Also refers to companies that |
||
| E-beam | Electron beam | manufacture such chips. | |
| EMEA | Europe, the Middle East and Africa | Metrology | The science of measurement on pattern quality before and during high-volume chip manufacturing. |
| ESG | Environmental, social and governance | N | |
| EU | European Union | ||
| EU-IFRS | International Financial Reporting Standards, a set of accounting rules issued by the International Accounting Standards Board, adopted by the European Union |
NA NAND |
Numerical aperture A binary logical operator that gives an output when it receives one or no input; a composite of 'NOT |
| Eurobond | A bond denominated in euros | AND'. | |
| Euronext Amsterdam | Euronext Amsterdam NV | Nasdaq | Nasdaq Stock Market LLC |
| EUV | A lithography technology that uses extreme ultraviolet (EUV) light with a wavelength of 13.5 nm – this is the cutting-edge of lithography and provides the highest resolution possible. |
nm NXE |
Nanometer (one billionth of a meter) ASML's first TWINSCAN platform for EUV lithography with a numerical aperture of 0.33 that provides |
| EXE | ASML's second TWINSCAN platform for EUV lithography, also referred to as EUV 0.55 NA or High | 13 nm resolution to support advanced Logic and Memory chip production, also referred to as EUV 0.33 NA. |
|
| F | NA EUV. | NXT | An enhanced version of the original TWINSCAN system platform offering significantly improved overlay and productivity. |
| Flash | A type of non-volatile memory used for storing and transferring information | O | |
| FTE | Full-time equivalent | OECD | Organisation for Economic Co-operation and Development |
| H | Overlay | The layer-to-layer alignment of chip structures | |
| Holistic lithography | Our approach to optimizing the entire microchip printing process and enabling affordable scaling in chip technology by integrating lithography systems with computational modeling and wafer metrology and inspection solutions to analyze and control the manufacturing process in real time. |
| ASML STATUTORY INTERIM REPORT 2025 |
|---|
| ------------------------------------ |
| Name | Description | ||
|---|---|---|---|
| P | |||
| Preference shares foundation |
Stichting Preferente Aandelen ASML | ||
| Productivity | The amount of wafers that is being exposed over a certain period of time, usually expressed in wafers per hour or wafers per day. |
||
| R | |||
| R&D | Research and development | ||
| T | |||
| Throughput | The number of wafers a system can process per hour | ||
| TWINSCAN | ASML's unique lithography system platform, with two complete wafer stages to allow one wafer to be mapped while another is being exposed, thereby enabling higher accuracy and throughput. |
||
| U | |||
| US GAAP | Generally accepted accounting principles in the United States of America | ||
| W | |||
| Wafer inspection | The process of locating and analyzing individual chip defects on a wafer | ||
| Wafer metrology | The process of measuring the quality of patterns on a wafer | ||
| Wavelength | The distance between two peaks of a wave such as light. The shorter the wavelength of light used in a lithography system, the smaller the features the system can resolve. |
||
| Website | www.asml.com | ||
| X | |||
| XT | ASML's second TWINSCAN platform for DUV lithography, with two complete wafer stages to allow one wafer to be mapped while another is being exposed, thereby enabling higher accuracy and throughput. |
||
| Y | |||
| YieldStar | ASML's optical diffraction-based wafer metrology platform |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.